These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745 [TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones and their effects on glucose transporters. Ciaraldi T; Henry RR Eur J Endocrinol; 1997 Dec; 137(6):610-2. PubMed ID: 9437223 [No Abstract] [Full Text] [Related]
10. Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats. Naderali EK; Pickavance LC; Wilding JP; Doyle PJ; Williams G Eur J Pharmacol; 2001 Mar; 416(1-2):133-9. PubMed ID: 11282122 [TBL] [Abstract][Full Text] [Related]
11. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes. Mishra SK; Aaronson PI Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472 [TBL] [Abstract][Full Text] [Related]
12. Effects of troglitazone on dexamethasone-induced insulin resistance in rats. Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576 [TBL] [Abstract][Full Text] [Related]
13. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus. O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828 [TBL] [Abstract][Full Text] [Related]
15. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis. Zhang B; Saku K; Arakawa K Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469 [TBL] [Abstract][Full Text] [Related]
16. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225 [TBL] [Abstract][Full Text] [Related]
18. A short synthesis of troglitazone: an antidiabetic drug for treating insulin resistance. Cossy J; Menciu C; Rakotoarisoa H; Kahn PH; Desmurs JR Bioorg Med Chem Lett; 1999 Dec; 9(24):3439-40. PubMed ID: 10617087 [TBL] [Abstract][Full Text] [Related]
19. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Fulgencio JP; Kohl C; Girard J; Pégorier JP Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats. Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]